Dr Omar Y Gonzalez, MD in Phoenix, AZ - Medicare Infectious Disease

Dr Omar Y Gonzalez, MD is a medicare enrolled "Internal Medicine - Infectious Disease" physician in Phoenix, Arizona. He graduated from medical school in 1996 and has 28 years of diverse experience with area of expertise as Infectious Disease. He is a member of the group practice Arizona Pulmonary Specialists Ltd and his current practice location is 3330 N 2nd St, Suite 300, Phoenix, Arizona. You can reach out to his office (for appointments etc.) via phone at (602) 443-0184.

Dr Omar Y Gonzalez is licensed to practice in Arizona (license number 31845) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1982637849.

Contact Information

	Dr Omar Y Gonzalez, MD
	3330 N 2nd St, Suite 300, Phoenix, AZ 85012-2368
	(602) 443-0184
	(602) 443-0187

Physician's Profile

Full Name	Dr Omar Y Gonzalez
Gender	Male
Speciality	Infectious Disease
Experience	28 Years
Location	3330 N 2nd St, Phoenix, Arizona
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Omar Y Gonzalez graduated from medical school in 1996

NPI Data:

NPI Number: 1982637849
Provider Enumeration Date: 07/07/2006
Last Update Date: 11/08/2011

Medicare PECOS Information:

PECOS PAC ID: 1759368863
Enrollment ID: I20081030000838

Medical Identifiers

Medical identifiers for Dr Omar Y Gonzalez such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1982637849	NPI	-	NPPES
862335-01	Medicaid	AZ

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RI0200X	Internal Medicine - Infectious Disease	31845 (Arizona)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
St. Joseph's Hospital And Medical Center	Phoenix, AZ	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Arizona Pulmonary Specialists Ltd	7618863192	45

News Archive

Inhibiting stress oxidant may be new therapy for COPD

The study "Oxidative Stress is an Important Component of Airway Inflammation in Mice Exposed to Cigarette Smoke or Lipopolysaccharide" investigates the inflammatory responses in oxidative stress-deficient mice exposed to cigarette smoke.

Novel approach for imaging immune cell movements identifies initial steps in inflammatory arthritis

Using a novel approach for imaging the movement of immune cells in living animals, researchers from the Massachusetts General Hospital Center for Immunology and Inflammatory Diseases have identified what appear to be the initial steps leading to joint inflammation in a model of inflammatory arthritis.

ALS TDI, Aestus Therapeutics to test potential small-molecule compounds to stop progression of ALS

The ALS Therapy Development Institute and Aestus Therapeutics, Inc., announced their plans today to test several potential small-molecule compounds to slow or stop the progression of Amyotrophic Lateral Sclerosis (ALS, Lou Gehrig's disease).

Chemical compound eCF506 may be highly effective at blocking growth of breast cancer cells

A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.

DAA medication could lead to revolution in hepatitis C treatment

The cost of treating hepatitis C virus (HCV) could be cut up to 50 percent if mathematical models are used to predict when patients can safely stop taking direct-acting antiviral (DAA) medication, according to a new study by researchers at Loyola University Health System and Loyola University Chicago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Omar Y Gonzalez allows following entities to bill medicare on his behalf.

Entity Name	Arizona Pulmonary Specialists Ltd
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1215986468 PECOS PAC ID: 7618863192 Enrollment ID: O20040223000693

News Archive

Inhibiting stress oxidant may be new therapy for COPD

Novel approach for imaging immune cell movements identifies initial steps in inflammatory arthritis

ALS TDI, Aestus Therapeutics to test potential small-molecule compounds to stop progression of ALS

Chemical compound eCF506 may be highly effective at blocking growth of breast cancer cells

A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.

DAA medication could lead to revolution in hepatitis C treatment

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Omar Y Gonzalez is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Omar Y Gonzalez, MD 3330 N 2nd St, Suite 300, Phoenix, AZ 85012-2368 Ph: (602) 261-7830	Dr Omar Y Gonzalez, MD 3330 N 2nd St, Suite 300, Phoenix, AZ 85012-2368 Ph: (602) 443-0184

News Archive

Inhibiting stress oxidant may be new therapy for COPD

Novel approach for imaging immune cell movements identifies initial steps in inflammatory arthritis

ALS TDI, Aestus Therapeutics to test potential small-molecule compounds to stop progression of ALS

Chemical compound eCF506 may be highly effective at blocking growth of breast cancer cells

A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.

DAA medication could lead to revolution in hepatitis C treatment

Internal Medicine Doctors in Phoenix, AZ

Moustafa I Hazin, D.O. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 500 W Thomas Rd, Suite 900, Phoenix, AZ 85013 Phone: 602-406-5590 Fax: 602-406-7165
Dr. Ali Shaheen Al-yaqoobi, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 2601 E Roosevelt St, Phoenix, AZ 85008 Phone: 602-344-5411
Dana Archbold, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1111 E Mcdowell Rd, Phoenix, AZ 85006 Phone: 602-839-2296 Fax: 602-839-2084
Catalina Nicole Flores, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 350 W Thomas Rd Dept Of, Phoenix, AZ 85013 Phone: 602-406-3000
Kristina Yancey, Infectious Disease Medicare: Medicare Enrolled Practice Location: 5777 E Mayo Blvd, Phoenix, AZ 85054 Phone: 480-342-2000
Dr. Francisco Cordova, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 29 W Edgemont Ave, Phoenix, AZ 85003 Phone: 602-263-8971 Fax: 602-263-8971
Dr. Dimpy Kapoor, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 9305 W Thomas Rd, Ste 455, Phoenix, AZ 85037 Phone: 623-399-9010 Fax: 623-399-9013

Dr Omar Y Gonzalez, MD - Medicare Infectious Disease in Phoenix, AZ

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Inhibiting stress oxidant may be new therapy for COPD

Novel approach for imaging immune cell movements identifies initial steps in inflammatory arthritis

ALS TDI, Aestus Therapeutics to test potential small-molecule compounds to stop progression of ALS

Chemical compound eCF506 may be highly effective at blocking growth of breast cancer cells

DAA medication could lead to revolution in hepatitis C treatment

Medicare Reassignments

Inhibiting stress oxidant may be new therapy for COPD

Novel approach for imaging immune cell movements identifies initial steps in inflammatory arthritis

ALS TDI, Aestus Therapeutics to test potential small-molecule compounds to stop progression of ALS

Chemical compound eCF506 may be highly effective at blocking growth of breast cancer cells

DAA medication could lead to revolution in hepatitis C treatment

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Inhibiting stress oxidant may be new therapy for COPD

Novel approach for imaging immune cell movements identifies initial steps in inflammatory arthritis

ALS TDI, Aestus Therapeutics to test potential small-molecule compounds to stop progression of ALS

Chemical compound eCF506 may be highly effective at blocking growth of breast cancer cells

DAA medication could lead to revolution in hepatitis C treatment

Internal Medicine Doctors in Phoenix, AZ